Results 11 to 20 of about 11,060 (223)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan

Global Heart, 2022
Background and Objectives: Implantation of implantable cardioverter-defibrillators (ICD) has increased significantly over the past decade. However, limited data exist regarding practices and policies of ICD implantations in Kazakhstan.
Temirkhan Begisbayev, Lyazzat Kosherbayeva, Valikhan Akhmetov, Dmitry Khvan, Marzhan Brimzhanova   +4 more
doaj   +4 more sources

Implantable cardioverter defibrillators [PDF]

Clinical Medicine, 2007
Sudden cardiac death occurs in 70,000-100,000 people annually in the UK, mostly in people with pre-existing heart disease but in 20% it is the first presentation Previous myocardial infarction (Ml) and significant left ventricular dysfunction are associated with a high rate of sudden cardiac death Implantable defibrillators are recommended in the ...
Stuart, Harris, Mehul, Dhinoja
openaire   +2 more sources

Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta‐Analysis of Randomized Trials and Propensity Score–Matched Studies

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Subcutaneous implantable cardioverter‐defibrillators (S‐ICDs) have been of great interest as an alternative to transvenous implantable cardioverter‐defibrillators (TV‐ICDs). No meta‐analyses synthesizing data from high‐quality studies have yet
Khi Yung Fong, Colin Jun Rong Ng, Yue Wang, Colin Yeo, Vern Hsen Tan   +4 more
doaj   +1 more source

Ventricular tachycardia prediction in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death

Indian Pacing and Electrophysiology Journal, 2019
Clinical data analysis of 83 patients with implantable cardioverter-defibrillators (ICDs) for sudden cardiac death (SCD) primary prevention has been done. We revealed 5 parameters associated with the detection of life-threatening ventricular arrhythmias.
Viktoria K. Lebedeva, Olga A. Klitcenko, Dmitry S. Lebedev, Tamara A. Lyubimtseva   +3 more
doaj   +1 more source

Continuous ST‐Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Newer implantable cardioverter defibrillators can monitor intracardiac ECGs , but their ability to detect ischemia is unclear. This study investigated the usefulness of implantable cardioverter defibrillators with an ST‐monitoring function in ...
Tetsuya Watanabe, Keiji Hirooka, Yoshio Furukawa, Masanori Yabuki, Akio Hirata, Kazunori Kashiwase, Ryu Shutta, Takanao Mine, Hiroya Mizuno, Toshikazu Tanaka, Takahiro Doi, Akihiro Yoshida, Yuji Okuyama, Shinsuke Nanto   +13 more
doaj   +1 more source

T-Wave Oversensing with Contemporary Implantable Cardioverter–Defibrillators

Journal of Cardiovascular Development and Disease, 2023
Background: Implantable cardioverter–defibrillators (ICDs) need to reliably detect ventricular tachycardia (VT) and ventricular fibrillation (VF) while avoiding T-wave oversensing (TWOS), which is associated with a risk of inappropriate therapies.
Marc Strik, Sylvain Ploux, Romain Eschalier, Pierre Mondoly, Leslie Fontagne, F. Daniel Ramirez, Michel Haïssaguerre, Pierre Bordachar   +7 more
doaj   +1 more source

Real‐World Disparities in Remote Follow‐Up of Cardiac Implantable Electronic Devices and Impact of the COVID‐19 Pandemic: A Single‐Center Experience

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Remote monitoring (RM) of cardiac implantable electronic devices has been shown to improve cardiovascular morbidity and mortality. To date, no studies have investigated disparities in use and delivery of RM.
H. Immo Lehmann, Krishan Sharma, Roma Bhatia, Theresa Mills, Joshua Lang, Guoping Li, Carl Andrews, Jay Cullivan, Jagmeet Singh, Theofanie Mela   +9 more
doaj   +1 more source

The implantable cardioverter‐defibrillator [PDF]

Clinical Cardiology, 2000
AbstractVentricular arrhythmias remain a major cause of cardiovascular mortality. Therapy for serious ventricular arrhythmias has evolved over the past decade, from treatment primarily with antiarrhythmic drugs to implanted devices. The implantable cardioverter‐defibrillator (ICD) is the best therapy for patients who have experienced an episode of ...
openaire   +2 more sources

Implantable cardioverter-defibrillator utilization [PDF]

Europace, 2011
Following the recent publication of our article1 concerning the European paradox with regard to implantable cardioverter defibrillator (ICD) device utilization in Europe (markedly lower device utilization in Europe compared with the USA), which updated several previous reports,2,3 …
John, Camm, Seah, Nisam
openaire   +2 more sources

Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis

Hellenic Journal of Cardiology, 2019
Background: Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) reduce sudden cardiac death and all-cause mortality in patients with heart failure with reduced ejection fraction (HFrEF).
Ahmed AlTurki, Riccardo Proietti, Hasan Alturki, Vidal Essebag, Thao Huynh   +4 more
doaj   +1 more source